Green Alpha Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $886K | Sell |
175,093
-3,780
| -2% | -$19.1K | 0.85% | 38 |
|
|
2025
Q1 | $946K | Buy |
178,873
+111,728
| +166% | +$591K | 1.01% | 28 |
|
|
2024
Q4 | $454K | Buy |
67,145
+2,346
| +4% | +$15.9K | 0.36% | 95 |
|
|
2024
Q3 | $427K | Buy |
64,799
+1,800
| +3% | +$11.9K | 0.34% | 96 |
|
|
2024
Q2 | $472K | Sell |
62,999
-9,435
| -13% | -$70.8K | 0.38% | 93 |
|
|
2024
Q1 | $722K | Buy |
72,434
+4,563
| +7% | +$45.5K | 0.52% | 75 |
|
|
2023
Q4 | $669K | Buy |
67,871
+33,329
| +96% | +$329K | 0.48% | 85 |
|
|
2023
Q3 | $264K | Buy |
+34,542
| New | +$264K | 0.2% | 131 |
|